Genmab Adr (GMAB)

Apr 21, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Apr 21, 2025

Apr 16, 2025

GMAB or RGEN: Which Is the Better Value Stock Right Now? - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

Genmab ADR (NASDAQ: GMAB) Jumps 1.19% In Recent Session. Here’s Everything You Need To Know. - Stocksregister

Apr 15, 2025

Apr 11, 2025

Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.

Apr 11, 2025

Apr 10, 2025

AGCO Corp (AGCO) Beta Value: Understanding the Market Risk - News Heater

Apr 10, 2025

Apr 04, 2025

Evercore Inc’s Mixed Bag: Down -29.24% in 6 Months, Down -20.22% in 30 Days - investchronicle.com

Apr 04, 2025

Mar 26, 2025

DLocal Limited (DLO) Shares Decline Despite Market Challenges - The News Heater

Mar 26, 2025

Mar 12, 2025

Genmab ADR Inc. (GMAB) Price Performance: The Role of Supply and Demand - The InvestChronicle

Mar 12, 2025

Feb 07, 2025

Views of Wall Street’s Leading Experts on Genmab ADR - SETE News

Feb 07, 2025

Feb 07, 2025

What is Core & Main Inc (CNM) Stock Return on Shareholders’ Capital? - SETE News

Feb 07, 2025

Feb 07, 2025

There is no doubt that Kite Realty Group Trust (KRG) ticks all the boxes. - SETE News

Feb 07, 2025

Jan 29, 2025

Sea Ltd ADR (NYSE: SE) Jumps 4.64%, Turning Investors Away - Stocks Register

Jan 29, 2025

Jan 29, 2025

Does Genmab ADR (NASDAQ: GMAB) Still Look Hot This Week? - Stocks Register

Jan 29, 2025

Jan 20, 2025

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - MSN

Jan 20, 2025

Jan 17, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN

Jan 17, 2025

Jan 14, 2025

Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance

Jan 14, 2025

Jan 08, 2025

Genmab stock holds Buy rating on positive trial results - Investing.com

Jan 08, 2025

Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024

Nov 12, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 12, 2024

Oct 16, 2024

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024

Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024

Aug 05, 2024

BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls - Yahoo Finance

Aug 05, 2024

Jul 29, 2024

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy - Yahoo Finance

Jul 29, 2024

Jul 15, 2024

RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com

Jul 15, 2024

Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024

Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024

Sep 05, 2023

Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch

Sep 05, 2023

Feb 23, 2023

Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily

Feb 23, 2023

Jan 23, 2023

GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada

Jan 23, 2023

Jan 11, 2023

New Strong Buy Stocks for January 11th - Yahoo Finance

Jan 11, 2023

Dec 12, 2022

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Dec 12, 2022

Dec 02, 2022

Oncolytics Biotech Inc. (ONCY) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Dec 02, 2022

Nov 24, 2022

Genmab's chief development officer sells shares in US - MedWatch

Nov 24, 2022

Nov 17, 2022

Genmab AS Sponsored ADR (GMAB) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Nov 17, 2022

Oct 17, 2022

INCY vs. GMAB: Which Stock Is the Better Value Option? - Yahoo Finance

Oct 17, 2022

May 10, 2022

Should You Buy Genmab (GMAB) Ahead of Earnings? - Yahoo Finance

May 10, 2022

Mar 29, 2021

Inside Genmab's blockbuster IPO - IR Magazine

Mar 29, 2021

Feb 24, 2021

Pipeline of Proprietary Antibodies - flow – Deutsche Bank

Feb 24, 2021

Feb 05, 2021

Genmab Stock Price, Quotes and Forecasts | NASDAQ:GMAB - Benzinga

Feb 05, 2021

Jan 13, 2021

Emergent BioSolutions Sees Its Composite Rating Rise To 97 - Investor's Business Daily

Jan 13, 2021

Jun 16, 2020

The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga

Jun 16, 2020

Aug 19, 2019

Genmab's offering and listing in the USA - Bech-Bruun

Aug 19, 2019

Aug 08, 2019

Genmab AS (GMAB) Stock Price, Trades & News - GuruFocus

Aug 08, 2019

Jul 21, 2019

Genmab (GMAB) - Zacks Investment Research

Jul 21, 2019

Jul 15, 2019

Genmab IPO: What You Need To Know - Benzinga

Jul 15, 2019